ONCOZENGE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.36 SEK | -0.59% |
|
-2.47% | +8.74% |
| 05-21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Total Return chart
